To save themselves, pharmaceutical companies will have to break up their giant R&D organizations, and put passionate scientists back in charge. From the May 2008 issue of Harvard Business Review.More
We've sent an email with your order details. Order ID #:
To access this title, visit your library in the app or on the desktop website.
Interesting thoughts about R&D in Big Pharma